Advanced search
Publication Cover
Cancer Biology & Therapy Volume 21, 2020 - Issue 9
Submit an article Journal homepage
1,428
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

High TKTL1 expression as a sign of poor prognosis in colorectal cancer with synchronous rather than metachronous liver metastases

Reetta Peltonena Transplantation and Liver Surgery, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, FinlandCorrespondence[email protected]
View further author information
,
Kaisa Ahopeltoa Transplantation and Liver Surgery, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;b Research Programs Unit, Translational Cancer Medicine, University of Helsinki, Helsinki, FinlandView further author information
,
Jaana Hagströmb Research Programs Unit, Translational Cancer Medicine, University of Helsinki, Helsinki, Finland;c Department of Pathology and Oral Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, FinlandView further author information
,
Camilla Böckelmanb Research Programs Unit, Translational Cancer Medicine, University of Helsinki, Helsinki, Finland;d Department of Gastrointestinal Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, FinlandORCID Iconhttps://orcid.org/0000-0002-1628-0305View further author information
ORCID Icon,
Caj Haglundb Research Programs Unit, Translational Cancer Medicine, University of Helsinki, Helsinki, Finland;d Department of Gastrointestinal Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, FinlandView further author information
&
Helena Isoniemia Transplantation and Liver Surgery, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;b Research Programs Unit, Translational Cancer Medicine, University of Helsinki, Helsinki, FinlandView further author information
Pages 826-831 | Received 26 Mar 2019, Accepted 17 Jul 2020, Published online: 14 Aug 2020

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;49:509.
  • Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, Aranda Aguilar E, Bardelli A, Benson A, Bodoky G, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27:1386–1422. doi:10.1093/annonc/mdw235.
  • House MG, Ito H, Gönen M, Fong Y, Allen PJ, DeMatteo RP, Brennan MF, Blumgart LH, Jarnagin WR, D’Angelica MI. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg. 2010;210:744–752. doi:10.1016/j.jamcollsurg.2009.12.040.
  • Peltonen R, Österlund P, Lempinen M, Nordin A, Stenman U-H, Isoniemi H. Postoperative CEA is a better prognostic marker than CA19-9, hCGβ or TATI after resection of colorectal liver metastases. Tumor Biol. 2018;40(1):1010428317752944. doi:10.1177/1010428317752944.
  • Xu X, Hausen Zur A, Coy JF, Löchelt M. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells. Int J Cancer. 2009;124:1330–1337. doi:10.1002/ijc.24078.
  • Ahopelto K, Böckelman C, Hagström J, Koskensalo S, Haglund C. Transketolase-like protein 1 expression predicts poor prognosis in colorectal cancer. Cancer Biol Ther. 2016;17:163–168. doi:10.1080/15384047.2015.1121347.
  • Kayser G, Sienel W, Kubitz B, Mattern D, Stickeler E, Passlick B, Werner M, Hausen Zur A. Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression. Pathology. 2011;43:719–724. doi:10.1097/PAT.0b013e32834c352b.
  • Chen H, Yue J-X, Yang S-H, Ding H, Zhao R-W, Zhang S. Overexpression of transketolase-like gene 1 is associated with cell proliferation in uterine cervix cancer. J Exp Clin Cancer Res. 2009;28:43. doi:10.1186/1756-9966-28-43.
  • Schwaab J, Horisberger K, Ströbel P, Bohn B, Gencer D, Kähler G, Kienle P, Post S, Wenz F, Hofmann W-K, et al. Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy. BMC Cancer. 2011;11:363. doi:10.1186/1471-2407-11-363.
  • Lange CA, Tisch-Rottensteiner J, Böhringer D, Martin G, Schwartzkopff J, Auw-Haedrich C. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome. Ophthalmology. 2012;119(9):1924–1929. doi:10.1016/j.ophtha.2012.03.037.
  • Grimm M, Munz A, Teriete P, Nadtotschi T, Reinert S. GLUT-1+/TKTL1+ coexpression predicts poor outcome in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117:743–753. doi:10.1016/j.oooo.2014.02.007.
  • Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015;41:729–741. doi:10.1016/j.ctrv.2015.06.006.
  • Diaz-Moralli S, Tarrado-Castellarnau M, Alenda C, Castells A, Cascante M. Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation. PLoS ONE. 2011;6(9):e25323. doi:10.1371/journal.pone.0025323.
  • Gong J, Cho M, Fakih M. RAS and BRAF in metastatic colorectal cancer management. J Gastrointest Oncol. 2016;7:687–704. doi:10.21037/jgo.2016.06.12.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.